Opportunity

CanadaBuys #SN25006

PMPRB Procurement of MIDAS Drug Pricing and Utilization Database from IQVIA

Posted

April 08, 2026

Respond By

April 23, 2026

Identifier

SN25006

NAICS

511210

The Patented Medicine Prices Review Board (PMPRB), a Canadian federal agency, is seeking to procure a comprehensive, commercially available database for drug pricing and utilization analysis across Canada and all OECD countries. - Government Buyer: - Patented Medicine Prices Review Board (PMPRB), Chief, Administrative and Procurement Services - OEM/Vendor Highlight: - IQVIA Solutions Canada Inc. (exclusive owner of the MIDAS database) - Products/Services Requested: - MIDAS Database for Drug Pricing and Utilization - Covers retail and hospital sectors - Includes market variables: price, quantities, revenue, product names, manufacturers, market segmentation - Data for Canada and all OECD countries - At least 10 years of historical data - Online BI tool access with export capabilities (Excel, CSV, PDF) - Customizable reporting and unlimited query management - Services: - At least 15 service hours for custom analytics, reporting, and expert advice - At least two web-based training sessions per year - 24x7 access and unlimited usage - Unique/Notable Requirements: - Data must be collected objectively and comprehensively from hospitals, pharmacies, and wholesalers - Non-competitive procurement due to exclusive rights held by IQVIA - Subject to multiple international trade agreements - Estimated Contract Value: - $1,827,550.32 USD - Period of Performance: - 11 months initial term, with two one-year option periods - Place of Performance/Delivery: - Ottawa, Canada (PMPRB office)

Description

The Patented Medicine Prices Review Board (PMPRB) is seeking a fully developed database containing drug utilization data for retail and hospital sectors, covering market variables such as price, quantities, and revenue of medicines sold in Canada and OECD countries. The database must be collected in a complete, objective, and non-biased manner through surveys across hospitals, pharmacies, and wholesalers. The contract duration is 11 months starting April 30, 2026, and the procurement method is non-competitive due to exclusive rights held by the pre-identified supplier. The database will support research on international price and market trends and must provide extensive data elements and functionalities including online access and export capabilities.

View original listing